TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26071228

Group type: EXPERIMENTAL
Intervention: Single haemodialysis session
Number of subjects: 28
Study: 23782126

Group type: EXPERIMENTAL
Intervention: 20 mg/kg/day BH4
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 21719096

Group type: EXPERIMENTAL
Intervention: Abatacept (10 mg/kg, maximum 1000 mg per dose) administered intravenously on days 1, 14, 28, and monthly for a total of 27 infusions over 2 years
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Abatacept
Number of subjects: 112
Study: 19302899

Group type: EXPERIMENTAL
Intervention: Tapentadol IR 50 mg
Number of subjects: 659

Group type: EXPERIMENTAL
Intervention: Tapentadol IR 75 mg
Number of subjects: 659

Group type: EXPERIMENTAL
Intervention: Oxycodone HCl IR 10 mg
Number of subjects: 659

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 659
Study: 17164971

Group type: EXPERIMENTAL
Intervention: 8 weeks of assisted exercise (daily passive extension and flexion range-of-motion exercise of the upper and lower extremities)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 8 weeks of assisted exercise
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 16
Study: 14749894

Group type: EXPERIMENTAL
Intervention: Paclitaxel
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Docetaxel
Number of subjects: 19
Study: 11843769

Group type: EXPERIMENTAL
Intervention: Heparin-coated circuit with leukocyte-depleting arterial line filter (HF group)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional circuit and arterial line filter (C group)
Number of subjects: 30
Study: 9669012

Group type: EXPERIMENTAL
Intervention: Positive pressure ventilation (PPV)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Spontaneous ventilation (SV)
Number of subjects: 164
Study: 7623530

Group type: EXPERIMENTAL
Intervention: Reteplase (two boluses of 10 MU given 30 min apart)
Number of subjects: 6010

Group type: COMPARATOR
Intervention: Streptokinase (1.5 MU intravenously over 60 min)
Number of subjects: 6010

Group type: EXPERIMENTAL
Intervention: Reteplase
Number of subjects: 6010

Group type: COMPARATOR
Intervention: Streptokinase
Number of subjects: 6010
Study: 2691421

Group type: EXPERIMENTAL
Intervention: Analgesic nitrous oxide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 1090193

Group type: EXPERIMENTAL
Intervention: methylphenidate
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: imipramine
Number of subjects: 76

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 76
Study: 31619250

Group type: EXPERIMENTAL
Intervention: Integrated Community-Based Health Systems Strengthening (ICBHSS) initiative
Number of subjects: 21

Group type: COMPARATOR
Intervention: Stepped-wedge cluster randomized control trial
Number of subjects: 21

Group type: COMPARATOR
Intervention: Annual health facility assessments
Number of subjects: 21

Group type: COMPARATOR
Intervention: Key informant interviews
Number of subjects: 21

Group type: COMPARATOR
Intervention: Costing and return-on-investment assessments for each randomized cluster
Number of subjects: 21
Study: 28531873

Group type: EXPERIMENTAL
Intervention: IU CBM‐I (active intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control CBM‐I (control condition)
Number of subjects: 0
Study: 26296595

Group type: EXPERIMENTAL
Intervention: SHARP Academic Asthma Health Education and Counseling Program
Number of subjects: 205

Group type: COMPARATOR
Intervention: Open Airways for Schools (Non-Academic Program)
Number of subjects: 205
Study: 23538293

Group type: EXPERIMENTAL
Intervention: Uphill interval-training programs
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Highest intensity uphill interval-training
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Middle intensity uphill interval-training
Number of subjects: 20
Study: 22069289

Group type: EXPERIMENTAL
Intervention: vitD3 (140,000 IU monthly)
Number of subjects: 59

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 59
Study: 19413683

Group type: EXPERIMENTAL
Intervention: Clonidine (0.01 mg min(‐1) IV, max 0.1 mg, placebo SC)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Sumatriptan (6 mg SC, placebo IV)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl IV and SC)
Number of subjects: 9
Study: 17045887

Group type: EXPERIMENTAL
Intervention: Manual thrombus aspiration before standard PPCI
Number of subjects: 148

Group type: COMPARATOR
Intervention: Standard PPCI
Number of subjects: 148
Study: 14514747

Group type: EXPERIMENTAL
Intervention: Pamidronate with vitamin D and calcium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vitamin D and calcium only (Control)
Number of subjects: 0
Study: 10841218

Group type: EXPERIMENTAL
Intervention: Systematic stenting (Wiktor stent)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Balloon angioplasty
Number of subjects: 211
Study: 9091692

Group type: EXPERIMENTAL
Intervention: Midodrine 10 mg, 3 times per day
Number of subjects: 171

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 171
Study: 7692636

Group type: EXPERIMENTAL
Intervention: FK‐506
Number of subjects: 72

Group type: COMPARATOR
Intervention: CsA
Number of subjects: 72
Study: 3911367

Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg twice daily
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Cimetidine 800 mg at night
Number of subjects: 108
Study: 29253122

Group type: EXPERIMENTAL
Intervention: Neoadjuvant therapy (chemotherapy)
Number of subjects: 134428

Group type: COMPARATOR
Intervention: Adjuvant therapy (chemotherapy)
Number of subjects: 134428
Study: 27457720

Group type: EXPERIMENTAL
Intervention: Acupuncture group (insertion of needles at specified points with electrical stimulation)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Sham acupuncture group (non-invasive needles adhered to skin at the same points)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Acupuncture group
Number of subjects: 72

Group type: COMPARATOR
Intervention: Sham acupuncture group
Number of subjects: 72
Study: 24374513

Group type: EXPERIMENTAL
Intervention: Pancreaticoduodenectomy with intraperitoneal drainage (drain group)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Pancreaticoduodenectomy without intraperitoneal drainage (no-drain group)
Number of subjects: 137
Study: 22576339

Group type: EXPERIMENTAL
Intervention: Conjunctive condition (performance determined by whichever partner stops exercising first)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Coactive condition (exercising alongside another person, independently)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Individual condition
Number of subjects: 58
Study: 20485282

Group type: EXPERIMENTAL
Intervention: Magnesium citrate (250 ml, day before procedure) followed by 2 liters PEG (day of procedure) - group 3
Number of subjects: 232

Group type: COMPARATOR
Intervention: 4 liters PEG (day before procedure) - group 1
Number of subjects: 232

Group type: COMPARATOR
Intervention: 2 liters PEG (day before procedure) followed by another 2 liters PEG (day of procedure) - group 2
Number of subjects: 232
Study: 17564825

Group type: EXPERIMENTAL
Intervention: Self-administered treatment
Number of subjects: 28

Group type: COMPARATOR
Intervention: Wait list control
Number of subjects: 28
Study: 16277633

Group type: EXPERIMENTAL
Intervention: Intervention group received printed self‐help materials and three‐session telephone‐based smoking cessation counselling delivered by trained counsellors
Number of subjects: 952

Group type: COMPARATOR
Intervention: Control group received printed self‐help materials only
Number of subjects: 952

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 952
Study: 12142115

Group type: EXPERIMENTAL
Intervention: Dose-adjusted warfarin (international normalized ratio 2 to 3)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Aspirin 75 mg and clopidogrel 75 mg combination therapy
Number of subjects: 70
Study: 10546382

Group type: EXPERIMENTAL
Intervention: Cyclocryocoagulation
Number of subjects: 5

Group type: COMPARATOR
Intervention: Trabeculectomy
Number of subjects: 5
Study: 7790321

Group type: EXPERIMENTAL
Intervention: Met‐depleting TPN with 5‐FU (500 mg/body per day; total 4.0 g/body) for 7 days before surgery
Number of subjects: 14

Group type: COMPARATOR
Intervention: Conventional L‐methionine‐containing TPN with 5‐FU
Number of subjects: 14
Study: 1693498

Group type: EXPERIMENTAL
Intervention: Krypton laser photocoagulation
Number of subjects: 49

Group type: COMPARATOR
Intervention: Observation only
Number of subjects: 49
Study: 1037257

Group type: COMPARATOR
Intervention: amitriptyline-N-oxide
Number of subjects: 15
Study: 31684880

Group type: EXPERIMENTAL
Intervention: Azospirillum (AL) with half dose of NP fertilizers (25 kg/ha N and 30 kg/ha P)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Azotobacter (AV) with half dose of NP fertilizers
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Azospirillum (AL) with half dose of NP fertilizers
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control (no treatment mentioned)
Number of subjects: 2
Study: 28173154

Group type: EXPERIMENTAL
Intervention: Extensive peritoneal lavage (10 l of saline)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Standard lavage (≤2 l of saline)
Number of subjects: 600
Study: 25460215

Group type: EXPERIMENTAL
Intervention: Full dose mCIMT (60 h)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Half dose mCIMT (30 h)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Half dose bimanual therapy (30 h)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Bimanual therapy (full dose)
Number of subjects: 82
Study: 23149871

Group type: EXPERIMENTAL
Intervention: Empagliflozin 100 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Empagliflozin (1 mg to 100 mg doses)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 48
Study: 28022576

Group type: EXPERIMENTAL
Intervention: TJ-107 (2.5 g three times daily)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: TJ-107
Number of subjects: 93
Study: 19015285

Group type: EXPERIMENTAL
Intervention: Statistical Process Control (SPC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Logistic Regression Risk Adjusted SPC (LR-SPC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bayesian Updating Statistic (BUS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control arms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intervention arms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trial A
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trial B
Number of subjects: 0
Study: 16393192

Group type: EXPERIMENTAL
Intervention: Professional treatment for drinking problems
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Broader treatment system including pretreatment assessment and additional forms of help
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Self-directed change during and following treatment
Number of subjects: 211
Study: 15242012

Group type: EXPERIMENTAL
Intervention: 24 g/d of resistant corn starch (RS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Regular corn starch (CS)
Number of subjects: 0
Study: 11589601

Group type: EXPERIMENTAL
Intervention: Distal splenorenal shunt (DSRS)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Devascularization procedure
Number of subjects: 219
Study: 9066993

Group type: EXPERIMENTAL
Intervention: 15 mg methylphenidate (MPH)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8327853

Group type: EXPERIMENTAL
Intervention: Fish oil
Number of subjects: 16

Group type: COMPARATOR
Intervention: Corn oil
Number of subjects: 16
Study: 3548382

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate
Number of subjects: 79

Group type: COMPARATOR
Intervention: Ritodrine hydrochloride
Number of subjects: 79
Study: 30868154

Group type: EXPERIMENTAL
Intervention: Tailored and adaptive computerized cognitive training
Number of subjects: 84

Group type: COMPARATOR
Intervention: Generic, non-tailored computerized cognitive training
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Self-efficacy intervention
Number of subjects: 84

Group type: COMPARATOR
Intervention: No self-efficacy condition
Number of subjects: 84
Study: 29713147

Group type: EXPERIMENTAL
Intervention: Amino acid supplementation (Aminoglutam®) administered twice a day for 4 weeks (96 kcal, 12 g amino acids, 0.18 g fat, 11.6 g carbohydrate, and vitamins B1, B6, and C)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Amino acid supplementation (Aminoglutam®)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study: 27723227

Group type: EXPERIMENTAL
Intervention: Basal insulin peglispro (BIL)
Number of subjects: 5371

Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 5371
Study: 24990028

Group type: EXPERIMENTAL
Intervention: High intensity personalized physical training (32 weeks, twice a week, optional extra session once a week)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (general recommendations regarding physical activity)
Number of subjects: 24
Study: 22920912

Group type: EXPERIMENTAL
Intervention: Intraaortic balloon counterpulsation (IABP)
Number of subjects: 600

Group type: COMPARATOR
Intervention: No intraaortic balloon counterpulsation (control)
Number of subjects: 600
Study: 20558500

Group type: EXPERIMENTAL
Intervention: Glatiramer acetate
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 19049698

Group type: COMPARATOR
Intervention: Sildenafil
Number of subjects: 190
Study: 15616230

Group type: EXPERIMENTAL
Intervention: Computer-assisted, patient-centered intervention
Number of subjects: 886

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 886
Study: 12672146

Group type: EXPERIMENTAL
Intervention: Rue (Ruta chalepensis) at 50% concentration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neem (Azadiracta indica) at 50% concentration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pyrethrum (Chrysanthemum cinerariaefolium) at 50% concentration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Deet at 50% concentration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Deet at 40% concentration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lemon eucalyptus at 40% concentration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pyrethrum at 40% concentration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Deet at 75% concentration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lemon eucalyptus at 75% concentration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pyrethrum at 75% concentration
Number of subjects: 0
Study: 10488276

Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 75

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 75

Group type: COMPARATOR
Intervention: Air
Number of subjects: 75
Study: 9101929

Group type: EXPERIMENTAL
Intervention: Application of RODER-loop and manual stump-sinking
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Application of RODER-loop without manual stump-sinking
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Application of Endo-GIA
Number of subjects: 140

Group type: COMPARATOR
Intervention: Conventional appendectomy according to McBurney
Number of subjects: 140
Study: 1680791

Group type: EXPERIMENTAL
Intervention: Zidovudine administered twice daily
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Zidovudine administered four times daily
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 6353433

Group type: EXPERIMENTAL
Intervention: Indoramin (25 mg twice daily) plus hydrochlorothiazide (25 mg twice daily) or propranolol (40 mg once daily)
Number of subjects: 30
Study: 31601947

Group type: EXPERIMENTAL
Intervention: Anti-beta1 adrenergic receptor antibody concentrations < median in STEMI patients ≤60 years
Number of subjects: 799

Group type: COMPARATOR
Intervention: Anti-beta1 adrenergic receptor antibody concentrations > median in STEMI patients ≤60 years
Number of subjects: 799

Group type: COMPARATOR
Intervention: All ACS patients
Number of subjects: 799
Study: 29029033

Group type: EXPERIMENTAL
Intervention: Levofloxacin (500 mg)
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg)
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Rifaximin (1650 mg)
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Levofloxacin
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Rifaximin
Number of subjects: 324

Group type: COMPARATOR
Intervention: All treatments
Number of subjects: 324
Study: 26068514

Group type: EXPERIMENTAL
Intervention: Community Health Assessment Programme through EMS (CHAP-EMS) intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 0
Study: 23816388

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression
Number of subjects: 93

Group type: COMPARATOR
Intervention: Compression stockings
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Autologous bypass grafts
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Polytetrafluoroethylene (PTFE) bypass grafts
Number of subjects: 93
Study: 21786549

Group type: EXPERIMENTAL
Intervention: Combined therapy group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Past procedure group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Historical control group
Number of subjects: 60
Study: 19344341

Group type: EXPERIMENTAL
Intervention: Pentagastrin
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 16700802

Group type: EXPERIMENTAL
Intervention: Eberconazole 1% cream every 12 h for 4 weeks
Number of subjects: 653

Group type: COMPARATOR
Intervention: Miconazole 2% cream every 12 h for 4 weeks
Number of subjects: 653

Group type: EXPERIMENTAL
Intervention: Eberconazole 1% cream
Number of subjects: 653

Group type: COMPARATOR
Intervention: Miconazole 2% cream
Number of subjects: 653
Study: 14715838

Group type: EXPERIMENTAL
Intervention: Estradiol replacement
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 11283883

Group type: EXPERIMENTAL
Intervention: Lactulose/rhamnose solution (1 mL/kg body weight) given at different time intervals after admission
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control patients (surgical controls)
Number of subjects: 23
Study: 9207820

Group type: EXPERIMENTAL
Intervention: Oral administration of misoprostol (400 micrograms)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Vaginal administration of misoprostol (400 micrograms)
Number of subjects: 20
Study: 8498608

Group type: EXPERIMENTAL
Intervention: 800 IU dl-alpha-tocopherol (vitamin E)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 3802701

Group type: EXPERIMENTAL
Intervention: Atenolol 50 mg daily
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg daily
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Atenolol 200 mg daily
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 29207087

Group type: EXPERIMENTAL
Intervention: p-STAT3 expression
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: p-STAT3 expression in luminal A subtype
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: p-STAT3 expression in luminal B subtype
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: p-STAT3 staining by IHC
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: p-STAT3 associated with recurrence risk
Number of subjects: 610
Study: 28627356

Group type: EXPERIMENTAL
Intervention: Aquatic therapy (AT) - 30 minutes, twice weekly for 6 months
Number of subjects: 12

Group type: COMPARATOR
Intervention: Land-based therapy (LBT)
Number of subjects: 12
Study: 26286137

Group type: EXPERIMENTAL
Intervention: Yoga class with yoga instructor
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Yoga at home
Number of subjects: 83

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 83
Study: 23135868

Group type: EXPERIMENTAL
Intervention: Aliskiren 150 mg/day (increased to 300 mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Valsartan 160 mg/day
Number of subjects: 40
Study: 21417623

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19046244

Group type: EXPERIMENTAL
Intervention: Brief psycho-educational intervention (2.5 days)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 114
Study: 16900245

Group type: EXPERIMENTAL
Intervention: Postconditioning (3 periods of 20 s of ischemia separated by 10 s of reperfusion)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Unrestricted reperfusion
Number of subjects: 10
Study: 12763375

Group type: EXPERIMENTAL
Intervention: Lamivudine monotherapy after a short course of HBIg and lamivudine
Number of subjects: 46

Group type: COMPARATOR
Intervention: Lamivudine plus HBIg for 1 month followed by lamivudine
Number of subjects: 46
Study: 10797336

Group type: EXPERIMENTAL
Intervention: Topical tetracycline (100 ml, 2 g)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 62
Study: 8712323

Group type: EXPERIMENTAL
Intervention: Vecuronium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rocuronium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Decamethonium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (uncooled arm)
Number of subjects: 0
Study: 1425642

Group type: EXPERIMENTAL
Intervention: BCAA supplementation (5.76, 2.88 and 2.88 g per day of leucine, isoleucine and valine, respectively)
Number of subjects: 16

Group type: COMPARATOR
Intervention: PLAC (placebo)
Number of subjects: 16
Study: 3975451

Group type: EXPERIMENTAL
Intervention: Increased quantity of alcohol per occasion and total lifetime consumption
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increased quantity of alcohol per occasion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Abstinence for two weeks
Number of subjects: 0
Study: 31340094

Group type: EXPERIMENTAL
Intervention: Erdafitinib (8 mg per day in a continuous regimen)
Number of subjects: 99
Study: 30254362

Group type: EXPERIMENTAL
Intervention: LA Health intervention
Number of subjects: 0
Study: 27239035

Group type: EXPERIMENTAL
Intervention: Fasting Mimicking Diet (FMD)
Number of subjects: 100